Bruin Lands De Novo On Pressure Ulcer Assessment Tool
Executive Summary
US FDA has granted a de novo clearance to Bruin Biometrics’ SEM Scanner, which is the first device cleared to assess parts of a patient’s body that may be at risk for pressure ulcers.
You may also be interested in...
Full Steam Ahead On Medtech Value-Based Business Models
Federal health-care policy in the US, at least, is potentially in for a major transition, but that is not having much of an impact on the fundamental business models of medtech firms and their ever-accelerating focus on value-based and risk-sharing business models. Emphasis on value strategies was a significant medtech theme at this year's JP Morgan Healthcare Conference bonanza.
J&J Subsidiary Pays $9.75M To Resolve Kickback Allegations
DePuy Synthes reportedly provided a Massachusetts surgeon with more than $100,000 in free implants and tools.
News We’re Watching – 20 January
This new Medtech Insight feature compiles news briefs on a range of US regulatory and legal happenings. This week: Congressional criticism of ClinicalTrials.gov, new radiation device performance standards, clearance of a new sepsis test and two new device classifications.